Intestinal transplantation: Current status and future directions

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 8, 2011, Pages 1221-1228

  Garg, Mayur ^a   Jones, Robert M ^a   Vaughan, Rhys B ^a   Testro, Adam G ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

Immunosuppression; Intestinal failure; Intestinal rehabilitation; Intestinal transplant; Liver intestine transplant; Multivisceral transplant; Parenteral nutrition

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; CAMPATH IH; CITRULLINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DACLIZUMAB; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VALGANCICLOVIR;

ABDOMINAL PAIN; ACUTE GRAFT REJECTION; AGANGLIONOSIS; ARTERIOSCLEROSIS; ARTICLE; AUSTRALIA; CATHETER INFECTION; CHRONIC GRAFT REJECTION; CLINICAL PROTOCOL; CORTICOSTEROID THERAPY; COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; CYTOMEGALOVIRUS INFECTION; DEHYDRATION; DRUG DOSE INCREASE; DRUG MEGADOSE; ENTEROPATHY; EXPERIENCE; FEEDING; FEVER; GASTROSCHISIS; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPEROXALURIA; ILEOSTOMY; IMMUNOSUPPRESSIVE TREATMENT; INTESTINAL FAILURE; INTESTINE ATRESIA; INTESTINE CANCER; INTESTINE INJURY; INTESTINE ISCHEMIA; INTESTINE MALROTATION; INTESTINE SURGERY; INTESTINE TRANSPLANTATION; INTESTINE VOLVULUS; LIVER FAILURE; LIVER FIBROSIS; LOW DRUG DOSE; MALABSORPTION; NECROTIZING ENTEROCOLITIS; NEPHROLITHIASIS; NUTRITION; ORGAN DONOR; PARENTERAL NUTRITION; PATIENT MONITORING; PATIENT REFERRAL; PORTAL HYPERTENSION; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION ENTEROPATHY; SINGLE DRUG DOSE; SURGICAL INFECTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT INDICATION; VENOUS THROMBOEMBOLISM;

EID: 79960462384     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06783.x     Document Type: Article

References (48)

1. Kirkman RL. Small bowel transplantation. Transplantation 1984; 37: 429-33.
2. Starzl TE, Rowe MI, Todo S etal. Transplantation of multiple abdominal viscera. JAMA 1989; 261: 1449-57.
3. Grant D, Wall W, Mimeault R etal. Successful small-bowel/liver transplantation. Lancet 1990; 335: 181-4.
4. Abu-Elmagd KM, Costa G, Bond GJ etal. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann. Surg. 2009; 250: 567-81.
5. Abu-Elmagd K, Bond G, Reyes J, Fung J. Intestinal transplantation: a coming of age. Adv. Surg. 2002; 36: 65-101.
6. Messing B, Crenn P, Beau P, Boutron-Ruault MC, Rambaud JC, Matuchansky C. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999; 117: 1043-50.
7. Messing B, Joly F. Guidelines for management of home parenteral support in adult chronic intestinal failure patients. Gastroenterology 2006; 130 (Suppl. 1): S43-51.
8. Carbonnel F, Cosnes J, Chevret S etal. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J. Parenter. Enteral. Nutr. 1996; 20: 275-80.
9. Matarese LE, O'Keefe SJ, Kandil HM, Bond G, Costa G, Abu-Elmagd K. Short bowel syndrome: clinical guidelines for nutrition management. Nutr. Clin. Pract. 2005; 20: 493-502.
10. Nightingale JM, Lennard-Jones JE, Walker ER, Farthing MJ. Jejunal efflux in short bowel syndrome. Lancet 1990; 336: 765-8.
11. Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000; 119: 1496-505.
12. Buchman AL. Etiology and initial management of short bowel syndrome. Gastroenterology 2006; 130 (Suppl. 1): S5-15.
13. Bines JE. Intestinal failure: a new era in clinical management. J. Gastroenterol. Hepatol. 2009; 24 (Suppl. 3): S86-92.
14. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann. Intern. Med. 2000; 132: 525-32.
15. Howard L, Heaphey L, Fleming CR, Lininger L, Steiger E. Four years of North American registry home parenteral nutrition outcome data and their implications for patient management. JPEN J. Parenter. Enteral. Nutr. 1991; 15: 384-93.
16. Chan S, McCowen KC, Bistrian BR etal. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery 1999; 126: 28-34.
17. Buchman AL, Iyer K, Fryer J. Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology 2006; 43: 9-19.
18. Abu-Elmagd KM. Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines. Gastroenterology 2006; 130 (Suppl. 1): S132-7.
19. Fishbein TM, Matsumoto CS. Intestinal replacement therapy: timing and indications for referral of patients to an intestinal rehabilitation and transplant program. Gastroenterology 2006; 130 (Suppl. 1): S147-51.
20. Grant D, Abu-Elmagd K, Reyes J etal. 2003 report of the intestine transplant registry: a new era has dawned. Ann. Surg. 2005; 241: 607-13.
21. Fryer J, Pellar S, Ormond D, Koffron A, Abecassis M. Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants. Liver Transpl. 2003; 9: 748-53.
22. Lloyd DA, Vega R, Bassett P, Forbes A, Gabe SM. Survival and dependence on home parenteral nutrition: experience over a 25-year period in a UK referral centre. Aliment. Pharmacol. Ther. 2006; 24: 1231-40.
23. Middleton SJ, Nishida S, Tzakis A etal. Cambridge-Miami score for intestinal transplantation preoperative risk assessment: initial development and validation. Transplant. Proc. 2010; 42: 19-21.
24. Abu-Elmagd KM. The small bowel contained allografts: existing and proposed nomenclature. Am. J. Transplant. 2011; 11: 184-5.
25. Cruz RJ Jr, Costa G, Bond G etal. Modified "liver-sparing" multivisceral transplant with preserved native spleen, pancreas, and duodenum: technique and long-term outcome. J. Gastrointest. Surg. 2010; 14: 1709-21.
26. Cicalese L, Sileri P, Green M, Abu-Elmagd K, Kocoshis S, Reyes J. Bacterial translocation in clinical intestinal transplantation. Transplantation 2001; 71: 1414-17.
27. Testa GB, Benedetti E. Role of living donor bowel transplantation in the treatment of intestinal failure in adults. Curr. Opin. Organ Transpl. 2006; 11: 247-50.
28. Delriviere L, Muiesan P, Marshall M etal. Size reduction of small bowels from adult cadaveric donors to alleviate the scarcity of pediatric size-matched organs: an anatomical and feasibility study. Transplantation 2000; 69: 1392-6.
29. Giovanelli M, Gupte GL, McKiernan P etal. Impact of change in the United Kingdom pediatric donor organ allocation policy for intestinal transplantation. Transplantation 2009; 87: 1695-9.
30. Pirenne J, Kawai M. Intestinal transplantation: evolution in immunosuppression protocols. Curr. Opin. Organ Transpl. 2009; 14: 250-5.
31. Fishbein TM. Intestinal transplantation. N. Engl. J. Med. 2009; 361: 998-1008.
32. Horslen SP. Optimal management of the post-intestinal transplant patient. Gastroenterology 2006; 130 (Suppl. 1): S163-9.
33. Sudan D. Cost and quality of life after intestinal transplantation. Gastroenterology 2006; 130 (Suppl. 1): S158-62.
34. Wu T, Abu-Elmagd K, Bond G, Nalesnik MA, Randhawa P, Demetris AJ. A schema for histologic grading of small intestine allograft acute rejection. Transplantation 2003; 75: 1241-8.
35. Sudan D, Vargas L, Sun Y, Bok L, Dijkstra G, Langnas A. Calprotectin: a novel noninvasive marker for intestinal allograft monitoring. Ann. Surg. 2007; 246: 311-15.
36. Mercer DF, Vargas L, Sun Y etal. Stool calprotectin monitoring after small intestine transplantation. Transplantation 2011; 91: 1166-71.
37. Gupte GL, Beath SV. Update on intestinal rehabilitation after intestinal transplantation. Curr. Opin. Organ Transpl. 2009; 14: 267-73.
38. Pirenne J, Kawai M. The protective effect of the liver: does it apply to the bowel too? Transplantation 2006; 81: 978-9.
39. Wagner HJ, Cheng YC, Huls MH etal. Prompt versus preemptive intervention for EBV lymphoproliferative disease. Blood 2004; 103: 3979-81.
40. Lacaille F, Vass N, Sauvat F etal. Long-term outcome, growth and digestive function in children 2 to 18years after intestinal transplantation. Gut 2008; 57: 455-61.
41. Akhavan A, Jackman SV, Costa G etal. Urogenital disorders associated with gut failure and intestinal transplantation. J. Urol. 2007; 178: 2067-72.
42. Watson MJ, Venick RS, Kaldas F etal. Renal function impacts outcomes after intestinal transplantation. Transplantation 2008; 86: 117-22.
43. Jeppesen PB, Langholz E, Mortensen PB. Quality of life in patients receiving home parenteral nutrition. Gut 1999; 44: 844-52.
44. DiMartini A, Rovera GM, Graham TO etal. Quality of life after small intestinal transplantation and among home parenteral nutrition patients. JPEN J. Parenter. Enteral. Nutr. 1998; 22: 357-62.
45. O'Keefe SJ, Emerling M, Koritsky D etal. Nutrition and quality of life following small intestinal transplantation. Am. J. Gastroenterol. 2007; 102: 1093-100.
46. Pironi L, Joly F, Forbes A etal. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut 2011; 60: 17-25.
47. Abu-Elmagd KM, Mazariegos G. Intestinal transplantation and the European implication: impact of experience and study design. Gut 2011 (in press).
48. Longworth L, Young T, Beath SV etal. An economic evaluation of pediatric small bowel transplantation in the United Kingdom. Transplantation 2006; 82: 508-15.